Author Login IJIRT Partner Network (IPN) Login

Epigenetic Modifiers: Key Players in Overcoming Cancer Resistance

  • Unique Paper ID: 174526
  • Volume: 11
  • Issue: 10
  • PageNo: 4241-4245
  • Abstract:
  • Cancer resistance remains a major challenge, reducing the effectiveness of chemotherapy, immunotherapy, and targeted therapies. Epigenetic modifications, like histone modifications and DNA methylation, regulate gene expression and contribute to tumor progression and drug resistance. Key epigenetic modifiers, including DNMTs, HDACs, KDMs, and PRMTs, have emerged as potential therapeutic targets. Epigenetic inhibitors, alone or in combination with conventional therapies, have shown promising outcomes in overcoming resistance and improving treatment outcomes. This review explores the role of epigenetic modifications in cancer resistance and highlights recent advancements in epigenetic-targeted therapies.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 11
  • Issue: 10
  • PageNo: 4241-4245

Epigenetic Modifiers: Key Players in Overcoming Cancer Resistance

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry